Symbol
| NME1
| contributors: mct/npt/pgu - updated : 20-12-2023
|
HGNC name
| non-metastatic cells 1, protein (NM23A) expressed in
|
HGNC id
| 7849
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| somatic mutation
|  
|  
|  
|
mutated in agressive neuroblastoma with a reduced expression in tumor progression to the metastatic phenotype | tumoral
|  
|  
| --over
|  
|
correlated with poor neuroblastoma patient outcomes | tumoral
|  
|  
| --low
|  
|
associated with aggressive forms of multiple cancers | tumoral
|  
|  
| --other
|  
|
its expression is associated with poor prognosis in peripheral T-cell lymphoma | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| NME1 may serve as a biomarker useful in the prediction of fetal circulatory centralization and extremely low birth weight in pregnancies complicated by the early-onset FGR (Fetal Growth Restrictio | Therapy target
| | |
| NME1-deficient mouse embryo fibroblasts grew poorly in culture, were more sensitive to stress than WT fibroblasts, and did not immortalize, which suggested that they senesce earlier than do WT fibroblasts |